Orphan Drugs 2025 _ Event Postponement
This is to inform that due to some circumstances beyond the organizer control, “2nd International Conference on Orphan Drugs and Rare Diseases” (ORPHAN DRUGS 2025) scheduled during March 13-15, 2025 in Rome, Italy has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at orphan-drugs@magnusconference.com or call + 1 (702) 988 2320.
2nd International Conference on Orphan Drugs and Rare Diseases
March 13-15, 2025
International Conference on
Orphan Drugs and Rare Diseases
Event Book
Event program
Scientific Program
About
Magnus Group extends its heartfelt gratitude to all the members of the Organizing Committee, Chairs, Co-chairs, Speakers, Students, Media Partners, and everyone who contributed to the conference's resounding success. The International Conference On Orphan Drugs and Rare Diseases was seamlessly executed as a Online Event from August 17-19, 2023. The Orphan Drugs 2023 Congress garnered an overwhelming response from participants.
Speakers
Sergey Suchkov
The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Vicki Ratner
ESSIC - International Society for the Study of BPS, United States
Kondakova O. B
National Medical Research Center for Children's Health Federal state autonomous institution of the Russian Federation Ministry of Health, Russian Federation
Paul L Kaufman
University of Wisconsin-Madison, United States
Magali Taiel
GenSight Biologics, France
Jiao Fuyong
Shaanxi Provincial People’s Hospital, China
Fereshteh Sedaghat
Sedaghat Memory Clinic, Iran (Islamic Republic of)
Daniel Scherman
Foundation for Rare Diseases, France
Harsha Rajasimha
Jeeva Clinical Trials, Inc, United States
Wang Huaixiu
Shanxi Provincial Hospital, China
Daniel Wainstock
Georgetown University-PUC-Rio, Brazil
Priyanka Wadhwa
Ikris Pharma Network Pvt Ltd, India
Zeynep Unluturk
University of Health Sciences Kocaeli Derince Training Hospital, Turkey
Roy G Beran
University of New South Wales, AustraliaGallery
Reviews
Title : The foundation for rare disease and its role in the european rare disease research landscape
Daniel Scherman, Foundation for Rare Diseases, France
Title : The effect of Eupalinolide B on amyotrophic lateral sclerosis: A case report
Wang Huaixiu, Shanxi Provincial Hospital, China
Title : Progress related in genetic research on kawasaki disease
Jiao Fuyong, Shaanxi Provincial People’s Hospital, China
Title : Covid-19 seems to be Initiated by the heparan-sulfate dysregulation by coronavirus: The use of low-molecular- weight heparin (LMWH) can prevent and treat covid-19 when it Is used in early stages, as a heparan-sulfate-regulating medicine
Fereshteh Sedaghat, Sedaghat Memory Clinic, Iran (Islamic Republic of)
Title : Lumevoq gene therapy in leber hereditary optic neuropathy
Magali Taiel, GenSight Biologics, France
Title : Drug recommendation system using a collaborative filtering in machine learning
J. Somasekar, Jain University, India